The agency launched Elsa 4.0, an upgrade to the agency’s internal AI tool available to all FDA staff, from scientific ...
Ensuring that proven therapies can be delivered safely and accessibly to the patients who need them provides opportunity in ...
PathAI’s best-in-class Image Management System (IMS) with advanced AI analysis and workflow capabilities, according to the ...
In healthcare, a cyber vulnerability is not just an IT problem. It can quickly become a patient-care problem.” ...
FDA Commissioner Marty Makary says, one-day inspections can strengthen our inspectional approach by focusing our time and ...
Edwards announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained ...
Next generation mitral valve, designed to facilitate patient lifetime management reports first uses in sternotomy, Minimally ...
SUNRISE-II feasibility trial marks the company’s entry into U.S. clinical development, advancing minimally invasive, anesthesia-free treatment approach ...
No longer a horizon technology, Artificial Intelligence in healthcare has reached a level of real-world performance that makes clinical value demonstrable at a critical time in healthcare – a time of ...
The FDA conducts approximately 12,000 domestic inspections and 3,000 foreign inspections each year in more than 90 countries. U.S. manufacturers undergo frequent, unannounced inspections, foreign ...
Patient Preference Information (PPI) guidance on when and what methods to use to collect and submit patient preference information (PPI) for a device to FDA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results